{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T20:47:42Z","timestamp":1774730862233,"version":"3.50.1"},"posted":{"date-parts":[[2026,3,26]]},"group-title":"Genomics","reference-count":72,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,3,26]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                <jats:p>\n                  Preclinical tuberculosis (TB) drug evaluation relies heavily on mouse infection models. Drug efficacy varies depending on inoculum and the timing of treatment initiation. These differences reflect, in part, physiological adaptations of\n                  <jats:italic>Mycobacterium tuberculosis<\/jats:italic>\n                  (\n                  <jats:italic>Mtb<\/jats:italic>\n                  ) to host immune pressure. We used novel molecular markers of pathogen health (RS ratio and SEARCH-TB) to contrast\n                  <jats:italic>Mtb<\/jats:italic>\n                  phenotypes in the BALB\/c high dose aerosol (HDA) subacute TB and low dose aerosol (LDA) chronic TB infection models, focusing on the transition from innate to adaptive immunity. We found that the onset of adaptive immunity coincided with a rapid reprogramming of\n                  <jats:italic>Mtb<\/jats:italic>\n                  physiology, characterized by suppressed respiration, metabolism, and biosynthesis, together with induction of stress and nutrient acquisition pathways. Changes in key\n                  <jats:italic>Mtb<\/jats:italic>\n                  processes were concordant with changes in host expression of canonical features of adaptive immunity. Our results also explain key model-specific differences in drug efficacy: when used for drug evaluation, the HDA model begins treatment during the innate immune phase when\n                  <jats:italic>Mtb<\/jats:italic>\n                  are metabolically active, whereas the LDA model initiates therapy after host adaptive immunity has already activated and the bacterial population is immune-constrained. The HDA model is shown to be a mixed model, spanning immune phases with initial treatment acting on replicating bacteria and later treatment acting on immune-constrained populations. Together, the two models offer complementary perspectives on therapeutic activity across the spectrum of bacterial states and provide a framework for designing regimens that are effective against both active and immune-constrained\n                  <jats:italic>Mtb<\/jats:italic>\n                  .\n                <\/jats:p>","DOI":"10.64898\/2026.03.26.714401","type":"posted-content","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T04:56:34Z","timestamp":1774587394000},"source":"Crossref","is-referenced-by-count":0,"title":["Adaptive immunity shapes baseline physiology of\n                  <i>M. tuberculosis<\/i>\n                  in high-dose versus low-dose infection BALB\/c mouse drug treatment models"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9029-2390","authenticated-orcid":false,"given":"Jo","family":"Hendrix","sequence":"first","affiliation":[{"name":"Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA"},{"name":"Rocky Mountain Regional VA Medical Center, Aurora, CO"},{"name":"Consortium for Applied Microbial Metrics, Aurora, CO"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reem Al","family":"Mubarak","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA"},{"name":"Rocky Mountain Regional VA Medical Center, Aurora, CO"},{"name":"Consortium for Applied Microbial Metrics, Aurora, CO"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Rossmassler","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA"},{"name":"Rocky Mountain Regional VA Medical Center, Aurora, CO"},{"name":"Consortium for Applied Microbial Metrics, Aurora, CO"},{"name":"Linda Crnic Institute for Down Syndrome, University of Colorado Anschutz Medical Campus, Aurora, CO, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holly","family":"Nielsen","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA"},{"name":"Rocky Mountain Regional VA Medical Center, Aurora, CO"},{"name":"Consortium for Applied Microbial Metrics, Aurora, CO"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Wynn","sequence":"additional","affiliation":[{"name":"Consortium for Applied Microbial Metrics, Aurora, CO"},{"name":"Center for Genes, Environment and Health, National Jewish Health, Denver, CO, USA"},{"name":"Department of Biostatistics and Informatics, University of Colorado Anschutz Medical Campus, Aurora, CO, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camile","family":"Moore","sequence":"additional","affiliation":[{"name":"Consortium for Applied Microbial Metrics, Aurora, CO"},{"name":"Center for Genes, Environment and Health, National Jewish Health, Denver, CO, USA"},{"name":"Department of Biostatistics and Informatics, University of Colorado Anschutz Medical Campus, Aurora, CO, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle L.","family":"Jones","sequence":"additional","affiliation":[{"name":"Consortium for Applied Microbial Metrics, Aurora, CO"},{"name":"Mycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9565-7923","authenticated-orcid":false,"given":"Martin I.","family":"Voskuil","sequence":"additional","affiliation":[{"name":"Consortium for Applied Microbial Metrics, Aurora, CO"},{"name":"Department of Immunology and Microbiology, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brendan K.","family":"Podell","sequence":"additional","affiliation":[{"name":"Consortium for Applied Microbial Metrics, Aurora, CO"},{"name":"Mycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7157-4034","authenticated-orcid":false,"given":"Gregory T.","family":"Robertson","sequence":"additional","affiliation":[{"name":"Consortium for Applied Microbial Metrics, Aurora, CO"},{"name":"Mycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuangqi","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Immunology and Microbiology, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0126-1993","authenticated-orcid":false,"given":"Nicholas D.","family":"Walter","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA"},{"name":"Rocky Mountain Regional VA Medical Center, Aurora, CO"},{"name":"Consortium for Applied Microbial Metrics, Aurora, CO"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2026032812500428000_2026.03.26.714401v1.1","unstructured":"Global Tuberculosis Report 2025. https:\/\/www.who.int\/teams\/global-programme-on-tuberculosis-and-lung-health\/tb-reports\/global-tuberculosis-report-2025."},{"key":"2026032812500428000_2026.03.26.714401v1.2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00595-10"},{"key":"2026032812500428000_2026.03.26.714401v1.3","doi-asserted-by":"crossref","unstructured":"Zhan, L. , Tang, J. , Sun, M. & Qin, C . Animal Models for Tuberculosis in Translational and Precision Medicine. Front. Microbiol. 8, 717 (2017).","DOI":"10.3389\/fmicb.2017.00717"},{"key":"2026032812500428000_2026.03.26.714401v1.4","doi-asserted-by":"publisher","DOI":"10.1055\/s-0028-1085705"},{"key":"2026032812500428000_2026.03.26.714401v1.5","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiv183"},{"key":"2026032812500428000_2026.03.26.714401v1.6","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12252"},{"key":"2026032812500428000_2026.03.26.714401v1.7","doi-asserted-by":"publisher","DOI":"10.1128\/aac.02266-17"},{"key":"2026032812500428000_2026.03.26.714401v1.8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002773"},{"key":"2026032812500428000_2026.03.26.714401v1.9","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1021\/acsinfecdis.5b00127","article-title":"Bedaquiline and Pyrazinamide Treatment Responses Are Affected by Pulmonary Lesion Heterogeneity in Mycobacterium tuberculosis Infected C3HeB\/FeJ Mice","volume":"2","year":"2016","journal-title":"ACS Infect. Dis"},{"key":"2026032812500428000_2026.03.26.714401v1.10","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3937"},{"key":"2026032812500428000_2026.03.26.714401v1.11","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1089\/mdr.2020.0179","article-title":"Differential Isoniazid Response Pattern Between Active and Dormant Mycobacterium tuberculosis","volume":"27","year":"2021","journal-title":"Microb. Drug Resist. Larchmt. N"},{"key":"2026032812500428000_2026.03.26.714401v1.12","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20040646"},{"key":"2026032812500428000_2026.03.26.714401v1.13","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkm485"},{"key":"2026032812500428000_2026.03.26.714401v1.14","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01727-19"},{"key":"2026032812500428000_2026.03.26.714401v1.15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0016161"},{"key":"2026032812500428000_2026.03.26.714401v1.16","doi-asserted-by":"publisher","DOI":"10.1038\/nm.1915"},{"key":"2026032812500428000_2026.03.26.714401v1.17","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.73.1.546-551.2005"},{"key":"2026032812500428000_2026.03.26.714401v1.18","doi-asserted-by":"crossref","unstructured":"McDaniel, M. M. , Krishna, N. , Handagama, W. G. , Eda, S. & Ganusov, V. V . Quantifying Limits on Replication, Death, and Quiescence of Mycobacterium tuberculosis in Mice. Front. Microbiol. 7, (2016).","DOI":"10.3389\/fmicb.2016.00862"},{"key":"2026032812500428000_2026.03.26.714401v1.19","doi-asserted-by":"crossref","unstructured":"Berg, A. et al. Model-Based Meta-Analysis of Relapsing Mouse Model Studies from the Critical Path to Tuberculosis Drug Regimens Initiative Database. Antimicrob. Agents Chemother. 66, e01793\u201321.","DOI":"10.1128\/aac.01793-21"},{"key":"2026032812500428000_2026.03.26.714401v1.20","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1038\/s41467-021-22833-6","article-title":"Mycobacterium tuberculosis precursor rRNA as a measure of treatment-shortening activity of drugs and regimens","volume":"12","year":"2021","journal-title":"Nat. Commun"},{"key":"2026032812500428000_2026.03.26.714401v1.21","doi-asserted-by":"publisher","DOI":"10.1038\/35021074"},{"key":"2026032812500428000_2026.03.26.714401v1.22","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20030846"},{"key":"2026032812500428000_2026.03.26.714401v1.23","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2436197100"},{"key":"2026032812500428000_2026.03.26.714401v1.24","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0507850102"},{"key":"2026032812500428000_2026.03.26.714401v1.25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2958.2010.07399.x"},{"key":"2026032812500428000_2026.03.26.714401v1.26","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.3390\/ijms23062961","article-title":"An In Vivo Model of Separate M. tuberculosis Phagocytosis by Neutrophils and Macrophages: Gene Expression Profiles in the Parasite and Disease Development in the Mouse Host","volume":"23","year":"2022","journal-title":"Int. J. Mol. Sci"},{"key":"2026032812500428000_2026.03.26.714401v1.27","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01066-13"},{"key":"2026032812500428000_2026.03.26.714401v1.28","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20030205"},{"key":"2026032812500428000_2026.03.26.714401v1.29","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0306023101"},{"key":"2026032812500428000_2026.03.26.714401v1.30","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.73.4.2533-2540.2005"},{"key":"2026032812500428000_2026.03.26.714401v1.31","doi-asserted-by":"publisher","DOI":"10.1128\/JB.00011-07"},{"key":"2026032812500428000_2026.03.26.714401v1.32","first-page":"e02363","article-title":"Transcriptional adaptation of Mycobacterium tuberculosis that survives prolonged multi-drug treatment in mice","volume":"14","year":"2023","journal-title":"mBio"},{"key":"2026032812500428000_2026.03.26.714401v1.33","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2008-0248OC"},{"key":"2026032812500428000_2026.03.26.714401v1.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2019.12.033"},{"key":"2026032812500428000_2026.03.26.714401v1.35","doi-asserted-by":"crossref","first-page":"848","DOI":"10.3390\/biology10090848","article-title":"Targeted RNA-Seq Reveals the M. tuberculosis Transcriptome from an In Vivo Infection Model","volume":"10","year":"2021","journal-title":"Biology"},{"key":"2026032812500428000_2026.03.26.714401v1.36","unstructured":"Canty, A. , Ripley, B. & Brazzale, A. R . boot: Bootstrap Functions. (2025)."},{"key":"2026032812500428000_2026.03.26.714401v1.37","first-page":"2114","article-title":"Trimmomatic: a flexible trimmer for Illumina sequence data","volume":"30","year":"2014","journal-title":"Bioinforma. Oxf. Engl"},{"key":"2026032812500428000_2026.03.26.714401v1.38","first-page":"15","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","year":"2013","journal-title":"Bioinforma. Oxf. Engl"},{"key":"2026032812500428000_2026.03.26.714401v1.39","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkw1134"},{"key":"2026032812500428000_2026.03.26.714401v1.40","unstructured":"Picard Tools - By Broad Institute. https:\/\/broadinstitute.github.io\/picard\/."},{"key":"2026032812500428000_2026.03.26.714401v1.41","doi-asserted-by":"crossref","unstructured":"Jiang, H. , Lei, R. , Ding, S.-W. & Zhu, S . Skewer: a fast and accurate adapter trimmer for next-generation sequencing paired-end reads. BMC Bioinformatics 15, 182 (2014).","DOI":"10.1186\/1471-2105-15-182"},{"key":"2026032812500428000_2026.03.26.714401v1.42","unstructured":"Staton, E . Pairfq. (2022)."},{"key":"2026032812500428000_2026.03.26.714401v1.43","doi-asserted-by":"crossref","unstructured":"Langmead, B. , Trapnell, C. , Pop, M. & Salzberg, S. L . Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 10, R25 (2009).","DOI":"10.1186\/gb-2009-10-3-r25"},{"key":"2026032812500428000_2026.03.26.714401v1.44","doi-asserted-by":"publisher","DOI":"10.1093\/BIOINFORMATICS\/BTAC166"},{"key":"2026032812500428000_2026.03.26.714401v1.45","doi-asserted-by":"crossref","unstructured":"Love, M. I. , Huber, W. & Anders, S . Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","DOI":"10.1186\/s13059-014-0550-8"},{"key":"2026032812500428000_2026.03.26.714401v1.46","doi-asserted-by":"publisher","DOI":"10.1089\/omi.2011.0118"},{"key":"2026032812500428000_2026.03.26.714401v1.47","doi-asserted-by":"publisher","DOI":"10.1111\/j.2517-6161.1995.tb02031.x)"},{"key":"2026032812500428000_2026.03.26.714401v1.48","first-page":"139","article-title":"edgeR: a Bioconductor package for differential expression analysis of digital gene expression data","volume":"26","year":"2010","journal-title":"Bioinforma. Oxf. Engl"},{"key":"2026032812500428000_2026.03.26.714401v1.49","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btz700"},{"key":"2026032812500428000_2026.03.26.714401v1.50","doi-asserted-by":"publisher","DOI":"10.1038\/24206"},{"key":"2026032812500428000_2026.03.26.714401v1.51","doi-asserted-by":"publisher","DOI":"10.1007\/s00357-014-9161-z"},{"key":"2026032812500428000_2026.03.26.714401v1.52","unstructured":"Topley and Wilson\u2019s Microbiology and Microbial Infections (Volume 1) - W. W. C. Topley ; Graham S. Wilson : 9780340885642 - AbeBooks. https:\/\/www.abebooks.com\/9780340885642\/Topley-Wilsons-Microbiology-Microbial-Infections-0340885645\/plp."},{"key":"2026032812500428000_2026.03.26.714401v1.53","doi-asserted-by":"crossref","unstructured":"Rahman, F . Characterizing the immune response to Mycobacterium tuberculosis: a comprehensive narrative review and implications in disease relapse. Front. Immunol. 15, (2024).","DOI":"10.3389\/fimmu.2024.1437901"},{"key":"2026032812500428000_2026.03.26.714401v1.54","doi-asserted-by":"crossref","unstructured":"Tsareva, A. et al. Aberrant adaptive immune response underlies genetic susceptibility to tuberculosis. Front. Immunol. 15, 1380971 (2024).","DOI":"10.3389\/fimmu.2024.1380971"},{"key":"2026032812500428000_2026.03.26.714401v1.55","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.3390\/ijms24021140","article-title":"Prolonged B-Lymphocyte-Mediated Immune and Inflammatory Responses to Tuberculosis Infection in the Lungs of TB-Resistant Mice","volume":"24","year":"2023","journal-title":"Int. J. Mol. Sci"},{"key":"2026032812500428000_2026.03.26.714401v1.56","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1721545115"},{"key":"2026032812500428000_2026.03.26.714401v1.57","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0001502"},{"key":"2026032812500428000_2026.03.26.714401v1.58","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24054725"},{"key":"2026032812500428000_2026.03.26.714401v1.59","doi-asserted-by":"crossref","unstructured":"Voskuil, M. I. , Bartek, I. , Visconti, K. & Schoolnik, G. K . The Response of Mycobacterium Tuberculosis to Reactive Oxygen and Nitrogen Species. Front. Microbiol. 2, (2011).","DOI":"10.3389\/fmicb.2011.00105"},{"key":"2026032812500428000_2026.03.26.714401v1.60","doi-asserted-by":"crossref","unstructured":"Zhang, Z. , Dong, L. , Li, X. , Deng, T. & Wang, Q . The PE\/PPE family proteins of Mycobacterium tuberculosis: evolution, function, and prospects for tuberculosis control. Front. Immunol. 16, 1606311 (2025).","DOI":"10.3389\/fimmu.2025.1606311"},{"key":"2026032812500428000_2026.03.26.714401v1.61","doi-asserted-by":"crossref","unstructured":"Vilch\u00e8ze, C. et al. Commonalities of Mycobacterium tuberculosis Transcriptomes in Response to Defined Persisting Macrophage Stresses. Front. Immunol. 13, 909904 (2022).","DOI":"10.3389\/fimmu.2022.909904"},{"key":"2026032812500428000_2026.03.26.714401v1.62","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12266"},{"key":"2026032812500428000_2026.03.26.714401v1.63","doi-asserted-by":"publisher","DOI":"10.1016\/S0952-7915(03)00075-X"},{"key":"2026032812500428000_2026.03.26.714401v1.64","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-022-00763-4"},{"key":"2026032812500428000_2026.03.26.714401v1.65","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiw364"},{"key":"2026032812500428000_2026.03.26.714401v1.66","doi-asserted-by":"publisher","DOI":"10.1126\/science.1088063"},{"key":"2026032812500428000_2026.03.26.714401v1.67","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1011495"},{"key":"2026032812500428000_2026.03.26.714401v1.68","doi-asserted-by":"publisher","DOI":"10.1172\/JCI114038"},{"key":"2026032812500428000_2026.03.26.714401v1.69","doi-asserted-by":"publisher","DOI":"10.1101\/2025.02.25.640123"},{"key":"2026032812500428000_2026.03.26.714401v1.70","unstructured":"Wynn, E. A . Emergence of antibiotic-specific Mycobacterium tuberculosis phenotypes during prolonged treatment of mice. Antimicrob Agents Chemother (IN PRESS)."},{"key":"2026032812500428000_2026.03.26.714401v1.71","first-page":"e00492","article-title":"Deconvoluting drug interactions using M. tuberculosis physiologic processes: transcriptional disaggregation of the BPaL regimen in vivo","volume":"0","year":"2025","journal-title":"Antimicrob. Agents Chemother"},{"key":"2026032812500428000_2026.03.26.714401v1.72","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/s41586-025-09286-3","article-title":"SuFEx-based antitubercular compound irreversibly inhibits Pks13","volume":"645","year":"2025","journal-title":"Nature"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.64898\/2026.03.26.714401","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T19:50:16Z","timestamp":1774727416000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.64898\/2026.03.26.714401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,26]]},"references-count":72,"URL":"https:\/\/doi.org\/10.64898\/2026.03.26.714401","relation":{},"subject":[],"published":{"date-parts":[[2026,3,26]]},"subtype":"preprint"}}